Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO). by Morgan, G. et al.
Career opportunities and beneﬁts
for young oncologists in the European
Society for Medical Oncology (ESMO)
Gilberto Morgan,1,2 Matteo Lambertini,3 Hampig Raphael Kourie,4
Teresa Amaral,5,6 Guillem Argiles,7 Susana Banerjee,8 Claudia Cardone,9
Jesus Corral,10 Letticia De Mattos-Arruda,11 Akif Öztürk,12 Mila Petrova,13
Laurids Poulsen,14 Michiel Strijbos,15 Alexandra Tyulyandina,16 Radu Vidra,17
Raffaele Califano,18 Evandro de Azambuja,4 Pilar Garrido Lopez,19
Valentina Guarneri,20 Martin Reck,21 Vladimir Moiseyenko,22 Erika Martinelli,23
Jean-Yves Douillard,24 Rolf Stahel,25 Emile Voest,26 Dirk Arnold,27
Fatima Cardoso,28 Paolo Casali,29 Andrés Cervantes,30
Alexander M M Eggermont,31 Alexandru Eniu,17 Jacek Jassem,32
George Pentheroudakis,33 Solange Peters,34 Keith McGregor,35 Stefan Rauh,36
Christoph C Zielinski,37 Fortunato Ciardiello,9 Josep Tabernero,38
Matthias Preusser37
To cite: Morgan G,
Lambertini M, Kourie HR,
et al. Career opportunities
and benefits for young
oncologists in the European
Society for Medical Oncology
(ESMO). ESMO Open 2016;1:
e000107. doi:10.1136/
esmoopen-2016-000107
▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
esmoopen-2016-000107).
Received 4 October 2016
Accepted 1 November 2016
For numbered affiliations see
end of article.
Correspondence to
Professor Matthias Preusser;
matthias.preusser@
meduniwien.ac.at
ABSTRACT
The European Society for Medical Oncology (ESMO) is
one of the leading societies of oncology professionals
in the world. Approximately 30% of the 13 000 ESMO
members are below the age of 40 and thus meet the
society’s definition of young oncologists (YOs). ESMO
has identified the training and development of YOs as a
priority and has therefore established a comprehensive
career development programme. This includes a
leadership development programme to help identify
and develop the future leaders in oncology. Well-
trained and highly motivated future generations of
multidisciplinary oncologists are essential to ensure the
optimal evolution of the field of oncology with the
ultimate goal of providing the best possible care to
patients with cancer. ESMO’s career development
portfolio is managed and continuously optimised by
several dedicated committees composed of ESMO
officers and is directly supervised by the ESMO
Executive Board and the ESMO President. It offers
unique resources for YOs at all stages of training and
includes a broad variety of fellowship opportunities,
educational courses, scientific meetings, publications
and resources. In this article, we provide an overview
of the activities and career development opportunities
provided by ESMO to the next generation of
oncologists.
INTRODUCTION
The specialty of medical oncology is relatively
young: it developed from internal medicine
in the 1960s, both in Europe and North
America. In 2014, the European Society for
Medical Oncology (ESMO) published a
position paper on the importance of the
medical oncologist as a core member in the
multidisciplinary team of healthcare profes-
sionals dealing with the management of
patients with cancer.1
The provision of high-quality training and
continuing medical education for young
oncologists (YOs) are key objectives for
ESMO. There are many challenges facing
the modern day oncologists, especially those
still in training. Although the problems may
differ depending on the country, guidance is
crucial for the development of the future
oncologists. ESMO was established with the
goal of promoting the ﬁeld of oncology at
several levels (box 1). In a world of globalisa-
tion, this goal has been modiﬁed, and ambi-
tion has taken ESMO to focus on Europe, as
well as on other parts of the world. ESMO
strives in being supportive of all its members
throughout their career. Through a variety of
educational resources and meetings, ESMO
fulﬁls particularly the needs of the YOs.
Hence, the ESMO Young Oncologists
Committee (YOC) was formed with the
purpose of promoting research, training and
networking within its young members,
regardless of geography.
As recently shown by two surveys in
Europe2 3 and one in the USA,4 YOs in train-
ing may face professional dissatisfaction,
burnout and challenges with work–life
balance. In this scenario, particular attention
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should be given to their education, professional oppor-
tunities and psychological challenges they have to face.
ESMO and the ESMO YOC
ESMO celebrated its 40th birthday in 2015. The current
membership has grown to over 13 000 individuals world-
wide and it continues to grow, reﬂecting, we believe, the
value of the services the society provides. The scope of
these services is extensive and of the highest quality.
The ﬁrst ESMO Congress was held in Nice in 1975,
the year ESMO was founded, and this has evolved into
one of the most important Congresses in the oncolo-
gist’s calendar. The ESMO Congress 2019 attracted
nearly 3000 abstract submissions and over 19 000 dele-
gates are expected. A range of ESMO subspecialty con-
gresses are also organised to cater to the needs of
members who have particular interests in speciﬁc sites.
The congresses provide important platforms for the
presentation of new practice changing data, education
and networking.
ESMO launched its ﬁrst journal in the 1990s, Annals of
Oncology (current Editor in Chief: Jean-Charles Soria,
Gustave Roussy Cancer Center, Villejuif, France). In
2015, ESMO debuted its ﬁrst fully open access online
journal, conveniently named ESMO Open (current
Editor in Chief: Christoph C Zielinski, Medical
University of Vienna, Vienna, Austria), responding to
the membership and society’s needs to publish both
research and policy articles.
ESMO continues to build bridges between continents,
oncology centres and generations of oncologists, estab-
lishing itself as a global player in the ﬁeld. The commit-
ment of the society towards its younger members led to
the development of the ESMO YOC. This committee was
created in 2001 as a full committee reporting to the
ESMO Executive Board on the career development
issues facing YOs. The ESMO YOC is composed of an
elected chair and selected members with a speciﬁc
mission: to provide opportunities that strengthen the
skills, knowledge and expertise of YOs throughout the
globe. This is done by the creation and implementation
of educational and scientiﬁc programmes that are rele-
vant to YOs in their daily practice and research.
Moreover, the ESMO YOC provides a suitable network-
ing platform for young medical oncologists and oncol-
ogy professionals.
The ‘ESMO YO’ is deﬁned as any ESMO member
under the age of 40 who is undergoing specialisation
training or is already qualiﬁed in oncology. Through
taking advantage of ESMO opportunities, YOs can keep
updated on the most innovative cancer research and
treatments, strengthening their knowledge and skills at
an international level. In 2016, out of the over 13 000
ESMO members, an estimated 5500 are YOs, half actively
interact and network through the YO website and social
media sites like the Facebook YO group. YOs are encour-
aged to take on leadership positions within the society
and make up of 8% of the current ESMO ofﬁcers.
The aim of this manuscript is to familiarise the
readers with the extensive beneﬁts that come with
ESMO membership, particularly for YOs. The ESMO
YO programmes can open the world to young members
by providing new opportunities, perhaps unattainable
at their home institute. This review is written by senior
oncologists and YOs from all over the world (ie,
Europe, North and South America, Asia and Africa).
Each of the authors and contributors has very unique
experiences and views, with one common thread:
ESMO has formed an intricate part in our develop-
ments as oncologists.
The ESMO programmes
There are a variety of programmes available for YOs.
This is an overview of some of these opportunities and
the impact they have had on younger oncologists
(table 1). The ESMO Preceptorship Programme pro-
vides YOs with training in the current standard of care
for a range of malignancies and is invaluable both for
those in training, or as a refresher course. Joint pro-
grammes such as the ESMO-European School of
Oncology (ESO) Masterclass in Clinical Oncology and
the Course on Medical Oncology for medical students
provide the right balance of research and educational
experience. The ESMO Academy and ESMO
Examination allow for the medical oncologist to refresh
their knowledge learnt during their training programme
and test the level of knowledge afterwards. The unique
ESMO Fellowship Programme comprises short-term and
long-term hospital-based programmes allowing inter-
action with top faculty in speciﬁc cancers or hands-on
training in some of the world’s most cutting-edge institu-
tions. Finally, this review will touch on the Young
Oncologist Track at the ESMO Congress and all the
tools the young oncologists have for their development.
Box 1 The European Society for Medical Oncology
(ESMO) Mission
▸ To improve the quality of prevention, diagnosis, treatment,
supportive and palliative care, as well as the follow-up of
patients with malignant disorders
▸ To advance the art, science, recognition and practice of
oncology
▸ To disseminate knowledge in oncology to patients with cancer
and the public
▸ To educate and train persons involved in clinical cancer care
and research
▸ To promote education in oncology in order to ensure a high
standard of qualification of medical oncologists within the
multidisciplinary team
▸ To facilitate equal access to optimal cancer care to all patients
with cancer
▸ To maintain liaisons with other oncology specialties, cancer
leagues, universities, patient groups and, where appropriate,
the pharmaceutical industry.
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Table 1 Overview of ESMO career development opportunities for young oncologists (for updated information, please refer to http://www.esmo.org
ESMO activity Required Language
Optimal age
and experience Held in
Room and
board
included
Travel
grant
available Length
ESMO membership* Proof of status English Anyone NA NA NA 1 year
ESMO Translational Research,
Clinical Research, Palliative
Care, European integration and
Georges Mathe translational
research fellowships
Application form, photograph,
description of research project
proposal+ timeline, motivation letter,
including project goals, acceptance
letter from mentor at host facility and
recommendation letter from the
applicant’s department head
English Young
oncologists
under the age
of 40
Various times No No Varies
ESMO ESO Masterclass CV, letter of motivation for attending
and letter of recommendation and a
presentation case
English 30–40 and 2–
3 years of
oncology
March Yes No 5 days
ESMO Academy† ‡ Application form English Anyone August Yes Yes 3 days
ESMO Examination Application form English (currently)
and other
languages currently
in consideration
Oncologists
nearing end of
training
September/
October during
ESMO
Congress
NA NA 2.5 hours
The ESMO ESO course on
medical oncology for medical
students
CV, letter of motivation for attending
and letter of recommendation
English Fourth-year and
fifth-year
medical
students
July Yes Yes 5 days
The ESMO Preceptorships Online application, CV and PPT
presentation
English Experience in
medical
oncology
Various times Yes Yes 2–3 days
All activities except the ESMO membership, Masterclasses and Examination are exclusive for ESMO members.
*Junior member price.
†Reduced price only if registered to take the ESMO Examination that year.
‡Early registration price.
CV, curriculum vitae; ESMO, European Society for Medical Oncology; ESO, European School of Oncology; NA, not available; PPT, PowerPoint Presentation.
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ESMO-ESO Masterclass
ESO is an organisation aiming to improve the skills of
all health professionals dealing with patients with
cancer; ESO’s mission is reﬂected in its motto ‘Learning
to Care’. It is the ofﬁcial partner of ESMO in organising
this masterclass since 2001, and in 2016 the ESO-ESMO
Masterclass celebrated its 15th anniversary of success. It
should be noted that during the same event, the
Masterclass in Nursing Oncology takes place with some
concomitant sessions and workshops between nurses
and physicians. This mixture of oncology personal
allows for a unique course dynamic where all aspects of
oncology can be addressed.
This clinically oriented 5-day residential course is
designed for medical or clinical oncologists with the
desire to improve their skills, as well as those preparing
for their national board examinations or the ESMO
Examination. This course covers a spectrum of topics in
clinical oncology; breast, gastrointestinal, genitourinary,
gynaecological, head and neck and lung cancers.
Spotlight sessions focusing on specialised topics like
communication skills, physical activity, cancer biology,
immunotherapy and advanced oncology nursing prac-
tice provide the participants with a good overview of
current cancer care. An international faculty of leading
experts offers plenary lectures regarding state-of-the-art
clinical management of all types of cancer. Every partici-
pant is required to present a clinical case either in the
tumour board or during small group sessions under the
supervision of the faculty. One of the particularities of
this masterclass is the opportunity to have informal dis-
cussion with the experts during the daily cocktail eve-
nings. All participants reside at the course venue, which
has a wonderful friendly ambiance and is excellent for
networking. Every minor detail of this event has been
planned and organised to maximise interaction between
colleagues in a relaxed atmosphere. The course materi-
als are available to the participants through the master-
class ofﬁcial website, which hosts lecture slides and
up-to-the-minute updates on the course. For young
members from the Balkan region, there is the
ESO-ESMO Eastern Europe and Balkan region
Masterclass. There is also another masterclass for young
members from South America. Both courses are
intended to cover the same range of topics as the main
ESO-ESMO Masterclass but are hosted at a different
time of the year.
More information is available at http://www.eso.net/
events-2.html.
ESMO translational and clinical research fellowships
For over 20 years, the ESMO Fellowship Programme has
supported YOs with valuable educational opportunities,
shaped professional lives and enhanced careers
(table 2). The ESMO fellowships provide YOs an oppor-
tunity to learn how to think scientiﬁcally, conduct
research according to rigorous standards and incorpor-
ate the latest scientiﬁc practices into daily practice. The
main aims are to promote professional development
and to provide research, education and opportunities
for networking under direct mentor supervision. The
ESMO Fellowship is an investment in the future:
through education in clinical and translational research,
the society yields a positive impact in the quality of
cancer care all over the world. There are both short-
term and long-term fellowships. The applicant must be
an ESMO member, an oncologist or oncologist in train-
ing under the age of 40, with some clinical experience
in internal medicine or medical, radiation or surgical
oncology and proﬁcient in English. The application
requirements can be found on the ESMO website.
Short-term fellowships
Short-term clinical and translational educational visits
lasting between a few days to 6 weeks and up to
3 months are available:
A. European integration fellowships: 6-week educational fel-
lowships offered to YOs practising in a country that
joined the European Union after 2004 or in a
European country classiﬁed by the World Bank as
Table 2 ESMO’s investment in the future
Total amount of fellowships Types of fellowships awarded
▸ 432 ESMO fellowships since 1989
▸ From 63 countries
▸ Hosted in about 95 institutes
▸ Total investment: over 7 million euros
Six fellowship programmes now available:
▸ 133 research fellowships
– 71 ESMO research (1989–2008)
– 50 translational research fellowships
– 12 clinical research fellowships
▸ 242 unit visits
– 176 translational research unit visits fellowships
– 4 European integration fellowships (new in 2016)
– 62 clinical unit visits fellowships
▸ 36 Palliative care fellowships
▸ 5 Georges Mathé fellowships (new in 2012)
ESMO, European Society for Medical Oncology.
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low, lower middle or upper middle income. The
main purpose is to gain ﬁrst-hand experience and
training on a tumour-speciﬁc area or special skill at a
leading European cancer institute recognised by
ESMO. For this fellowship, the applicant does not
need to make contact with possible host institutes
beforehand; ESMO will match the wishes of the awar-
dees with a suitable host institute.
B. Clinical unit visits: 6-week individual fellowships that
offer YOs the opportunity to gain insight into clinical
research at leading European centres of excellence.
This is a unique opportunity to gain deep intuitive
understanding of oncology care and to support
efforts to expand professional networks within
leading European institutions. The applicant needs
to contact a host institute to organise the clinical
visit, outlining a detailed programme, and obtain the
approval and conﬁrmation of the host and home
institutes.
C. Translational research unit visits: 3–4-day visits at a
European institution of excellence in translational
research. These are educational events for YOs inter-
ested in having exposure to translational research at
a top cancer centre and aim to help YOs understand
how to design and manage research projects. These
group visits take place at various different institutes
during the year.
D. ESMO palliative care fellowships: this is a unique experi-
ence to gain training in palliative care. The recipient
of this fellowship will spend a minimum of 1 month
and a maximum of 3 months of observation or
research at one of the ESMO Designated Centres of
Integrated Oncology and Palliative Care. It is the
responsibility of the fellow to identify and contact the
ESMO designated centre.
Long-term fellowships
The longer term research-based ESMO fellowships have
durations between 1 and 2 years and are available to
undertake both clinical and translational oncology
research projects. The application for long-term fellow-
ships also requires a detailed research project proposal
including timelines, an acceptance letter from the
mentor (ie, the person responsible for the project at
the host institute) and a letter of recommendation from
the candidate’s department head at the home institute.
The ESMO Fellowship and Award Committee that
reviews the applications focuses on the overall quality of
the application, as well as on the project proposed in
terms of overall strategy, methodology and the suggested
analyses of the research data as well as project feasibility
(ie, to accomplish the speciﬁc aims within the grant
term). The following two fellowships are available:
A. ESMO clinical research fellowships: 1-year fellowship
aiming to provide YOs training in clinical research in
renowned European cancer centres. The main
purpose is to provide the necessary support to
develop clinical oncology research projects and to
expand professional networks through collaboration
with institutions of excellence.
B. ESMO translational research fellowships: 1-year fellowship
with a possible second-year prolongation on request
and subsequent approval. The Translational Research
Fellowship represents a comprehensive bench-to-
bedside training in translational research in
European centres of excellence. The main purposes
are to provide the necessary support to develop spe-
ciﬁc high-quality translational research projects in
oncology and to improve career development
through collaboration with European institutions of
excellence.
Other ESMO events for YOs
The ESMO Academy is an interactive 3-day meeting taking
place in Oxford, England, designed to give a general
and in-depth update about the major topics in medical
oncology. The teaching faculty for this course is made
up of some of the most prestigious names in the ﬁeld.
The course is aimed at oncology professionals intending
to take the ESMO Examination during that same year. It
provides an extensive oncology overview and helps you
to understand the ESMO Examination process and ques-
tion format through a high-tech lecture and participa-
tion system using electronic tablets. Through these
methods, the participant will be able to pinpoint gaps in
their knowledge and improve on them. For those just
interested in a refresher course, the ESMO Academy will
provide updates for participants on the current stan-
dards of care for the main malignancies and the sup-
porting trials. All of the ESMO Academy lectures are
available at the end of session via webcast in
OncologyPRO. Dr Fernandes Pimentel, a medical
oncologist from Brazil, attended the ﬁrst-ever ESMO
Academy in 2015 and found the experience to have a
paramount role in his preparation for the ESMO
Examination and also for his oncology boards in Brazil.
He felt that the ESMO Academy was the right mixture
of learning lectures, interaction with colleagues and a
friendly atmosphere in a beautiful setting. This course is
highly recommended to residents, trainees, fellows and
practitioners worldwide who are preparing for the
ESMO Examination and also want a general overview.
Those expressing interest in this course should take
advantage of early registration as space is limited to 250
spots. Priority and a reduced price are given to those
who have registered for the ESMO Examination that
year. The cost of meals and lodging is included in the
academy fee; however, there is also ﬁnancial assistance
available for applicants needing help with travel costs.
The ESMO-ESO course on medical oncology for medical stu-
dents is a collaboration with the aim of exposing fourth-
year and ﬁfth-year medical students to medical oncology
and the current day therapies and challenges in the
ﬁeld. Forty-ﬁve students are selected to undergo a highly
condensed 5-day residential learning experience which
maximises exposure to oncology and motivates students
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into joining the ever-evolving world of oncology.
Through case-based learning, interactive lectures and
workshops, students are exposed to oncology in a multi-
disciplinary approach and supplement their already
present knowledge of oncology. This course promotes
constant dialogue and gives students the opportunity to
consult with some of the best international oncology
experts in the ﬁeld. There is a ﬁnal test at the end of
the course and the student with the highest score is
offered to participate in the ESMO Congress that year.
Katarzyna Rachunek, a medical student in Poland and
previous participant of the ESMO-ESO medical student
course, feels that ‘the greatest value of the lectures was
the possibility to interact and discuss with top academic
experts in medical oncology as it reinforced the import-
ance of clinical research and evidence-based medicine
in oncology’. The intent with such early exposure is to
promote the ﬁeld of oncology to medical students to
inspire them to become future medical oncologists.
The ESMO Preceptorship Programme: Throughout the
year, ESMO offers preceptorship courses that are highly
condensed and informative courses that focus on spe-
ciﬁc tumour sites. The ESMO Preceptorships are educa-
tional courses that aim to present the current standard
of care for a given malignancy in accordance with the
ESMO clinical practice guidelines. The courses are con-
ducted by leading experts in a particular ﬁeld of oncol-
ogy. These meetings provide the oncologists with a
complete multidisciplinary understanding of the man-
agement of the disease from diagnosis to treatment. All
major malignancies are covered in the programme and
courses are organised in Europe and Asia.
Preceptorships are held over 2–3 days and allow for
close interaction with the faculty through didactic learn-
ing, case studies and open discussions. These closed
meetings host 60–100 delegates per course from all
around the world. Participants are provided a great plat-
form to interact with the faculty and colleagues and
share experiences and ideas. Attendance to these events
is by application and the process is competitive. The
application requires the applicant’s curriculum vitae and
list of publications, and a ﬁve-slide clinical case presenta-
tion on the topic of the preceptorship. Cases with the
most merit will be chosen by the faculty and are pre-
sented to the group by the participant. Dr Surendra Pal
Chaudhary from India never thought he would ever
meet the authors and innovators whose articles and
research he had read and practised in his everyday
clinic; yet through the ESMO Preceptorship, this
became a reality. The preceptorship covers all of the
aspects of disease, from epidemiology, diagnosis,
advanced treatments, future goals and effective cancer
therapies in the world. Dr Pal Chaudhary has attended
many preceptorships and he testiﬁes that through such
ESMO activities, his knowledge, experience and skills
have been taken to a new level and have improved his
conﬁdence as an oncologist. Through knowledge gath-
ered by his experiences with ESMO, he has help to
improve and expand his urological malignancies clinic
in India and provide better services to his community.
However, he realises that without ESMO this would not
have been possible as “ﬁnancial support is the biggest
limitation for YOs, especially in less developed and
poorly served countries; without the support of ESMO, it
wouldn’t have been possible to attend such activities and
improve my clinic”. This is an investment ESMO has
made in Europe and in other countries like India, allow-
ing for doctors to return to their home institution and
apply this new-found knowledge and ideas. Oncologists
in Asia are not the only ones taking advantage of these
opportunities; in Africa, doctors like Karima Oualla
from Morocco are also beneﬁting from such preceptor-
ships and keeping up to date with the latest techniques:
“working in Morocco with limited access to modern tar-
geted therapy, it is a great opportunity to be able to
learn about the practical uses of these treatments and
eventual side-effects according to the most updated
guidelines”.
An aspect that is unique to the ESMO Preceptorships is
the kind of networking that such an avenue allows. Owing
to its intimate setting, it facilitates discussions and
exchanges of ideas. ESMO encourages all of its members
to apply, but priority is given to YOs. For the oncologists
after their training, preceptorships are also a good way to
make recertiﬁcation easier through continued medical
education (CME) credits which are awarded at the end of
the course (8–10 ESMO-Medical Oncologist’s
Recertiﬁcation Approval (MORA) points). Preceptorships
are awarded on a competitive basis and there is no regis-
tration cost. In addition, applicants qualify for a travel
grant up to €600, facilitating transport especially for our
colleagues participating from other continents.
The ESMO Leadership Generation Programme: This is an
ESMO Executive Board initiative and was founded and
developed by the ESMO Fellowship and Award
Committee in 2016. The programme is aimed at ‘high
potential’ ESMO members aged between 31 and 45.
The course is organised in two blocks of 3 days each and
includes comprehensive education in ESMO’s structure
and activities as well as intensive training in leadership,
communication and media skills. In 2016, the ﬁrst
ESMO leaders generation programme was held and had
15 participants, who were selected based on recommen-
dation and nomination by a senior ESMO member
(ESMO Executive Board Member, ESMO National
Representative or ESMO YOC chair). One of the ﬁrst
participants to the programme was Dr Michiel Strijbos
from Belgium, who best describes his experience as “An
exceptional programme under the leadership of some
of the most experienced oncologists in ESMO, hosted in
a beautiful venue and with the company of colleagues
that share a common passion for oncology and our
society”. For future editions of the programme, self-
nominations with support from senior colleagues or
mentors are foreseen and selection will be performed
competitively.
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Other ways ESMO contributes to the development of its
members
The ESMO Examination is intended for YOs nearing the
end of their oncology training. This valuable knowledge
based test is primarily offered by ESMO to assess the
applicant’s knowledge at the end of the training period.
A pass score on the ESMO Examination conﬁrms that
the applicant’s level of knowledge in medical oncology is
excellent and the achievement of passing the examin-
ation is highly regarded in many countries. The ESMO
Examination serves as part of the board certiﬁcation
requirement in medical oncology for Switzerland and
Slovenia. Presently, the examination is only offered in
English, but the ESMO Executive Board is currently dis-
cussing offering the examination in several frequently
spoken languages to increase its utility to the wider com-
munity. The examination is held annually at the ESMO
Congress and simultaneously in several other cities in the
world and is available for a fee (note: there is a remark-
able difference in price between early and normal regis-
tration). Registration to the ESMO Examination makes
you eligible for a lower fee in the ESMO Academy.
The Young Oncologist Track at ESMO Congresses: This
track, available during every ESMO Congress, began in
2002 and was designed with YOs in mind. The Young
Oncologist Track is a series of educational lectures, inter-
active seminars and networking events (eg, the YO
Networking Evening) that are designed to be a platform
for discussion and networking among oncologists who
have applied and participated in speciﬁc ESMO fellow-
ships. Many lectures are designed to guide the YOs,
including lectures on publishing, fellowships, internships
and other opportunities.
There are a number of online resources offered by
ESMO that are of great beneﬁt in an oncology practice.
One of these resources is OncologyPRO, which is free and
unlimited to all ESMO members. Through this website,
members can download all of the ESMO publications,
including handbooks and guidelines, watch oncology web-
casts, download slides from previous ESMO meetings and
have the opportunity to watch E-learning and V-learning
modules from leading oncology experts and accrue CME
points. ESMO members also have complete access to
Annals of Oncology, both online and printed versions.
A valuable tool for everyday practice is OncoAssist. This
application offers the user adjuvant tools, prognostic
scores, formulas, an AJCC staging manual and a CTCAE
score. OncoAssist is free of cost to ESMO members and
can be downloaded to desktops, tablets or smartphones.
Another useful web tool is the Young Oncologist Corner:
this is the YOC’s webpages on esmo.org where
announcements are made on new fellowships, precep-
torships and ESMO opportunities. There are monthly
challenges that give oncologists an opportunity to put
their diagnostic skills to the test with the initiative
Images in Oncology: these are images from peculiar
cases that are submitted by other YOs around the world
and promote dialogue among colleagues. The YOC’s
webpages also contain webcasts, presentations, slides,
posters and an online journal club, all with the purpose
of aiding in the YO’s professional development.
In the era of social media, the ESMO Young
Oncologist Facebook group helps ESMO YO members
stay connected. This is a close group of over 2500
members (mostly medical oncologists) from around the
globe. Here, YOs can discuss cases, events, share experi-
ences regarding all of the ESMO opportunities and
most importantly network and keep each other updated
on international opportunities in this increasingly
shrinking oncology world.
CONCLUSION
Oncology is a rapidly evolving, always transforming spe-
cialty. The development of innovative technologies, new
markers or techniques and novel therapeutics makes it a
fascinating ﬁeld; however, it is vital to our practice that we
keep up to date. ESMO programmes are designed with
this in mind, allowing the developing oncologist to work
side by side with leaders in the ﬁeld. ESMO believes that
in order for oncology to continue its amazing progress, it
is necessary that oncologists discuss, share ideas and col-
laborate closely. The opportunities provided by ESMO
facilitate the gathering of minds and the building of rela-
tionships both at a professional and personal level. The
investment ESMO makes in its member beneﬁts the
society and participating oncologists, as well as the institu-
tion and the country from which the oncologists come.
This is one of the reasons ESMO is committed to its
members in developing countries, in and outside Europe.
There is no better time to be a YO; new treatment
options, immunotherapy and precision oncology are
paving the way to the therapies of tomorrow, and ESMO
will be there every step of the way. Through fellowships
and a vast amount of educational opportunities, YOs will
stay on top of the changes that are happening, improv-
ing their knowledge and most importantly the quality of
care they provide. ESMO knows that investing in the
younger generation will shape oncology in the future:
this is why these development opportunities are free of
cost, with the sole requirement of ESMO membership
which is offered at a reduced price for members in train-
ing. Oncology should not be different depending on
geography: ESMO believes the same to be true about
oncology training. For both oncologists in training and
young members already specialised who want to keep
updated on the changes in oncology, ESMO has several
opportunities to offer. Hence, on behalf of the authors
and contributors of the article, this is an invitation to
join ESMO and to take advantage of the many oppor-
tunities available, as regardless of the countries of prac-
tice, we are all ESMO.
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